IMMX

Immix Biopharma, Inc.

Latest Form 4:Purchase$5KbyMorris Gabriel S (CFO) · filed Dec 10, 2025

Immix Biopharma, Inc. (IMMX) has 11 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: May 29, 2026.

  • Industry:Biotechnology
  • CEO:Ilya Rachman
  • Employees:21
  • HQ:Los Angeles, CA, US
  • IPO:2021-12-16

Insider Buying

$20K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$1.0B

latest known value

Source
Purchase$5KDec 10SEC ↗
Purchase$5KDec 10SEC ↗
Rachman Ilya MFirst filing
Purchase$5KSep 17SEC ↗
Morris Gabriel SFirst filing
Purchase$5KSep 17SEC ↗

Related companies

Immix Biopharma, Inc. is in the Healthcare sector.